Research ArticleClinical Studies
Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary
DIRK RADES, TRANG NGUYEN, MAI TRONG KHOA, STEFAN JANSSEN and STEVEN E. SCHILD
Anticancer Research April 2020, 40 (4) 2261-2264; DOI: https://doi.org/10.21873/anticanres.14189
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
2Faculty of Medicine, Hanoi Medical University, Hanoi, Vietnam
TRANG NGUYEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
MAI TRONG KHOA
2Faculty of Medicine, Hanoi Medical University, Hanoi, Vietnam
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
3Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
STEVEN E. SCHILD
4Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
In this issue
Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary
DIRK RADES, TRANG NGUYEN, MAI TRONG KHOA, STEFAN JANSSEN, STEVEN E. SCHILD
Anticancer Research Apr 2020, 40 (4) 2261-2264; DOI: 10.21873/anticanres.14189
Jump to section
Related Articles
- No related articles found.